Radiofrequency Ablation (RFA)
Treatment for Liver Cancer Due To Alcohol Use
Effectiveness
80%
Safety Score
70%
Clinical Trials
50
Participants
10K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate tumor destruction, clinical outcome assessed within weeks
Treatment Duration
Single session, may be repeated for recurrence
Evidence Quality
HIGHNumber Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
20(Treat 20 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$18,000
Side Effect Mgmt:$3,000
Total Annual:$21,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$50,000/QALY
QALYs Gained
1.5
Outcome-Based Costs
Cost per Responder
$26,250
Cost per Remission
$32,308
Comparison vs TACE
Cost Difference
$-5,000/year
Less expensive
QALY Difference
+0.10 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Radiofrequency Ablation (RFA) Outcomes
for Liver Cancer Due To Alcohol Use
Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+80%
Remission Rate
+65%
Common Side Effects
Post-ablation syndrome (fever, pain)
+30%
Bleeding
+3%
Infection
+1%
Thermal injury to adjacent organs
+1%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov